CARMAT
Develops an implantable artificial heart as a bridge-to-transplant for heart failure patients.
ALCAR | PA
Overview
Corporate Details
- ISIN(s):
- FR0010907956
- LEI:
- 969500ARXACM0P0KH333
- Country:
- France
- Address:
- 36 AVENUE DE L'EUROPE, 78140 VELIZY-VILLACOUBLAY
- Website:
- https://www.carmatsa.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
CARMAT is a medical technology company that designs and develops advanced therapeutic solutions for cardiovascular diseases. The company's primary innovation is the Aeson® total artificial heart, a fully implantable and autoregulated device designed to replace the native ventricles of a failing heart. It is intended for patients with end-stage biventricular heart failure, serving as a critical bridge-to-transplant solution for those awaiting a donor organ. CARMAT aims to provide a lasting therapeutic option for a condition with limited effective treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-15 07:30 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 227.2 KB | ||
| 2025-10-15 07:30 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 229.5 KB | ||
| 2025-10-01 07:30 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 223.9 KB | ||
| 2025-10-01 07:30 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 233.0 KB | ||
| 2025-07-03 18:30 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 218.4 KB | ||
| 2025-06-20 19:10 |
Regulatory News Service
Inside Information / Other news releases
|
English | 524.8 KB | ||
| 2025-06-20 19:10 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 276.0 KB | ||
| 2025-06-20 18:39 |
Capital/Financing Update
Inside Information / Other news releases
|
English | 223.7 KB | ||
| 2025-06-20 18:39 |
Capital/Financing Update
Informations privilégiées / Autres communiqués
|
French | 241.7 KB | ||
| 2025-06-04 17:45 |
Pre-Annual General Meeting Information
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 183.1 KB | ||
| 2025-06-02 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 196.9 KB | ||
| 2025-06-02 07:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 155.3 KB | ||
| 2025-06-02 07:00 |
Business and Financial Review
Informations privilégiées / Autres communiqués
|
French | 152.4 KB | ||
| 2025-05-12 18:00 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 279.6 KB | ||
| 2025-05-12 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 197.2 KB |
Automate Your Workflow. Get a real-time feed of all CARMAT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CARMAT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CARMAT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-29 | N/A | Other | Other | 375,939 | 1,499,996.61 EUR |
| 2024-01-29 | N/A | Other | Other | 62,656 | 249,997.44 EUR |
| 2023-10-23 | N/A | Other | Other | 1,944,442 | 6,999,991.20 EUR |
| 2023-10-23 | N/A | Other | Other | 1,041,666 | 3,749,997.60 EUR |
| 2023-10-23 | N/A | Other | Other | 138,888 | 499,996.80 EUR |
| 2023-10-19 | N/A | Other | Sell | 10,000 | 33,200.00 EUR |
| 2023-10-15 | N/A | Other | Other | 1,041,666 | 3,749,997.60 EUR |
